In the context of T2D, the ability of GIP to stimulate insulin secretion and to ameliorate glycaemia is impaired [35]
GLP-1 (glucagon-like peptide-1) receptor agonists, such as Semaglutide , are a class of medications originally developed for the treatment of type 2 diabetes but have also gained recognition for their role in weight management
That means maintaining strength, supporting bone health, improving metabolic fitness, and reducing injury risk
GLP-1 receptor agonists like Ozempic basically tell your stomach to slow down, which is great for blood sugar control and appetite, but leads to constipation, says Michael Bass, MD, a board-certified gastroenterologist and hepatologist and the founding medical director of Oshi Health
While muscle cramps are not listed as a common side effect in FDA labeling, some patients report experiencing them during treatment
Its also important to note that any evidence showing some of these supplements may temporarily increase GLP-1 is limited
